← Back to headlines
GeneDx Reports Strong Q4 Earnings and Reaffirms 2026 Revenue Guidance
GeneDx saw its stock rise following a strong performance in the fourth quarter, exceeding expectations. The company also reiterated its revenue guidance for 2026, signaling confidence in its future financial outlook.
23 Feb, 18:01 — 23 Feb, 18:01
ℹOnly 1 source covers this story
